Expands AbbVie's neuroscience portfolio, adding first-in-class modulators of the synaptic vesicle protein 2A, including lead molecule SDI-118 currently in Phase 1b studies
Fyarro added to NCCN guidelines as the only preferred mTOR inhibitor to treat malignant PEComa
Zydus unveils its ‘innovation and care’ centric corporate brand identity
The newly enhanced drug development platform will help empower innovators with the fastest development timelines
The capex during the last nine months has been around Rs 110 crores which is all funded through internal accruals
Adds five years of market exclusivity on approval
Twist will leverage C2i’s leadership in whole-genome cancer signatures across solid cancers to generate unique synthetic reference materials for cancer detection validation in labs across the globe
Newly formed Life Science Services business unit to offer fully integrated CDMO and Contract Testing Services
ImmunIgY, has been developed by ReaGene Biosciences, Kyntox Bio and ProdigY, and is an antibody-containing beverage that can potentially prevent viral entry, regardless of vaccination or infection status
Astec LifeSciences has reported its financial performance for the quarter ended December 31, 2021
Subscribe To Our Newsletter & Stay Updated
